Cargando…

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

BACKGROUND: Despite effective antiretroviral treatment (ART), HIV-positive individuals are at increased risk of serious non-AIDS conditions (cardiovascular, liver and renal disease, and cancers), perhaps due in part to ongoing inflammation and/or coagulation. To estimate the potential risk reduction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grund, Birgit, Baker, Jason V, Deeks, Steven G., Wolfson, Julian, Wentworth, Deborah, Cozzi-Lepri, Alessandro, Cohen, Calvin J., Phillips, Andrew, Lundgren, Jens D., Neaton, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865234/ https://www.ncbi.nlm.nih.gov/pubmed/27171281 http://dx.doi.org/10.1371/journal.pone.0155100

Ejemplares similares

Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy
por: Miller, Christopher J., et al.
Publicado: (2014)

LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
por: Babiker, Abdel G, et al.
Publicado: (2022)

Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts
por: Sherman, Brad T., et al.
Publicado: (2021)

A bioinformatic approach to identify new potential resistance relevant amino acid substitutions (AAS) in HIV-1 protease (H1P)
por: Frederiksen, Casper M, et al.
Publicado: (2009)

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015
por: Dwyer, Dominic E, et al.
Publicado: (2017)

Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

When to start antiretroviral therapy: the need for an evidence base during early HIV infection
por: Lundgren, Jens D, et al.
Publicado: (2013)

Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study
por: Serrano-Villar, Sergio, et al.
Publicado: (2023)

Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies
por: Lynfield, Ruth, et al.
Publicado: (2014)

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death
por: Casadellà, Maria, et al.
Publicado: (2017)

Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy
por: Ruggiero, Alessandra, et al.
Publicado: (2018)

Cases of a Serious Morbid Affection
Publicado: (1821)

Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008
por: Abo, Yao, et al.
Publicado: (2013)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies
por: Davey, Richard T., et al.
Publicado: (2013)

CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy
por: Madeddu, Giordano, et al.
Publicado: (2014)

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death
por: Casadellà Fontdevila, Maria, et al.
Publicado: (2014)

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
por: Baker, Jason V, et al.
Publicado: (2017)

Timing of Antiretroviral Therapy Initiation after a First AIDS-Defining Event: Temporal Changes in Clinical Attitudes in the ICONA Cohort
por: Cingolani, Antonella, et al.
Publicado: (2014)

Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe
por: Zoufaly, Alexander, et al.
Publicado: (2014)

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
por: Phillips, Patrick P. J., et al.
Publicado: (2019)

Morbidity and mortality of serious gastrointestinal complications after lung transplantation
por: Zevallos-Villegas, Annette, et al.
Publicado: (2019)

2453: Serious cardiovascular morbidity and mortality in a cohort of adults with Fontan physiology
por: Weingarten, Angela, et al.
Publicado: (2018)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Can Linear Regression Modeling Help Clinicians in the Interpretation of Genotypic Resistance Data? An Application to Derive a Lopinavir-Score
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2011)

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017)

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy
por: Di Biagio, Antonio, et al.
Publicado: (2016)

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ
por: Ruggiero, Alessandra, et al.
Publicado: (2015)

Identification of a Cytotoxic Form of Dimeric Interleukin-2 in Murine Tissues
por: Wrenshall, Lucile E., et al.
Publicado: (2014)

High Prevalence of Tuberculosis and Serious Bloodstream Infections in Ambulatory Individuals Presenting for Antiretroviral Therapy in Malawi
por: Bedell, Richard A., et al.
Publicado: (2012)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
por: Mondi, Annalisa, et al.
Publicado: (2019)

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France
por: de Monteynard, Laure-Amélie, et al.
Publicado: (2018)

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
por: Costarelli, Silvia, et al.
Publicado: (2016)

Factors Associated with D-Dimer Levels in HIV-Infected Individuals
por: Borges, Álvaro H., et al.
Publicado: (2014)

Another piece in the COVID-19 treatment puzzle
por: Mussini, Cristina, et al.
Publicado: (2022)

Serious neonatal morbidities are associated with differences in DNA methylation among very preterm infants
por: Everson, Todd M., et al.
Publicado: (2020)

Using Health Surveillance Systems Data to Assess the Impact of AIDS and Antiretroviral Treatment on Adult Morbidity and Mortality in Botswana
por: Stoneburner, Rand, et al.
Publicado: (2014)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7a1i864tue3hknbvllf1esu3r5